|
|
Volumn 2, Issue 1, 2000, Pages 76-89
|
|
The role of new agents in advanced non-small-cell lung carcinoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BIOLOGICAL RESPONSE MODIFIER;
BRIDGED COMPOUND;
CAMPTOTHECIN;
CISPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
IRINOTECAN;
NAVELBINE;
TAXANE;
TAXOID;
VINBLASTINE;
ADULT;
AGE;
AGED;
CANCER STAGING;
COMPUTER ASSISTED TOMOGRAPHY;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METHODOLOGY;
MIDDLE AGED;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PATHOLOGY;
PROGNOSIS;
QUALITY OF LIFE;
REVIEW;
SURVIVAL;
ADULT;
AGE FACTORS;
AGED;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOLOGICAL RESPONSE MODIFIERS;
BRIDGED COMPOUNDS;
CAMPTOTHECIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
DEOXYCYTIDINE;
HUMANS;
LUNG NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
MIDDLE AGED;
NEOPLASM STAGING;
PROGNOSIS;
QUALITY OF LIFE;
SURVIVAL ANALYSIS;
TAXOIDS;
TOMOGRAPHY, X-RAY COMPUTED;
VINBLASTINE;
|
|
EID: 0033732703
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-000-0014-z Document Type: Review |
|
Times cited : (15)
|
|
References (148)
|
